IT8547939A0 - Liposomi contenenti interleucina, metodo per la loro preparazione eloro uso terapeutico nelle affezioni tumorali - Google Patents

Liposomi contenenti interleucina, metodo per la loro preparazione eloro uso terapeutico nelle affezioni tumorali

Info

Publication number
IT8547939A0
IT8547939A0 IT8547939A IT4793985A IT8547939A0 IT 8547939 A0 IT8547939 A0 IT 8547939A0 IT 8547939 A IT8547939 A IT 8547939A IT 4793985 A IT4793985 A IT 4793985A IT 8547939 A0 IT8547939 A0 IT 8547939A0
Authority
IT
Italy
Prior art keywords
interleucin
preparation
therapeutic use
liposomes containing
cancer diseases
Prior art date
Application number
IT8547939A
Other languages
English (en)
Other versions
IT1199967B (it
IT8547939A1 (it
Inventor
Kissel Thomas
Jurg Reinhard
Schrank Henriette
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848409127A external-priority patent/GB8409127D0/en
Priority claimed from GB848409126A external-priority patent/GB8409126D0/en
Priority claimed from GB848409125A external-priority patent/GB8409125D0/en
Priority claimed from GB848409128A external-priority patent/GB8409128D0/en
Priority claimed from GB848420381A external-priority patent/GB8420381D0/en
Priority claimed from GB848423701A external-priority patent/GB8423701D0/en
Priority claimed from GB848423700A external-priority patent/GB8423700D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8547939A0 publication Critical patent/IT8547939A0/it
Publication of IT8547939A1 publication Critical patent/IT8547939A1/it
Application granted granted Critical
Publication of IT1199967B publication Critical patent/IT1199967B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT47939/85A 1984-04-09 1985-04-09 Liposomi contenenti interleucina,metodo per la loro preparazione e loro uso terapeutico nelle affezioni tumorali IT1199967B (it)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB848409127A GB8409127D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409126A GB8409126D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409125A GB8409125D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409128A GB8409128D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848420381A GB8420381D0 (en) 1984-08-10 1984-08-10 Interleukin therapy
GB848423701A GB8423701D0 (en) 1984-09-19 1984-09-19 Interleukin therapy
GB848423700A GB8423700D0 (en) 1984-09-19 1984-09-19 Interleukin therapy

Publications (3)

Publication Number Publication Date
IT8547939A0 true IT8547939A0 (it) 1985-04-09
IT8547939A1 IT8547939A1 (it) 1986-10-09
IT1199967B IT1199967B (it) 1989-01-05

Family

ID=27562708

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47939/85A IT1199967B (it) 1984-04-09 1985-04-09 Liposomi contenenti interleucina,metodo per la loro preparazione e loro uso terapeutico nelle affezioni tumorali

Country Status (13)

Country Link
US (1) US4863740A (it)
JP (1) JPH0665650B2 (it)
AU (1) AU4094685A (it)
CH (1) CH668554A5 (it)
DE (1) DE3512926A1 (it)
DK (1) DK155085A (it)
FR (1) FR2562421B1 (it)
GB (1) GB2157172B (it)
IL (1) IL74835A0 (it)
IT (1) IT1199967B (it)
LU (1) LU85839A1 (it)
NL (1) NL8501010A (it)
SE (1) SE8501709L (it)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
DE3682257D1 (de) * 1985-11-22 1991-12-05 Takeda Chemical Industries Ltd Liposomzusammensetzung.
EP0274219A3 (en) * 1986-12-04 1988-08-03 Takeda Chemical Industries, Ltd. Interleukin-2-containing liposome composition and method for the production thereof
FR2624741B1 (fr) * 1987-12-21 1991-06-28 Pasteur Institut Compositions a base d'une combinaison de liposomes et de lymphokine presentant des proprietes immunostimulantes et leurs applications en medecine humaine et veterinaire
JPH03505576A (ja) * 1988-05-16 1991-12-05 ネクスター・フアーマシユーテイカルズ・インコーポレイテツド 有機化合物に関する改良
EP0577146A3 (en) * 1988-05-16 1994-02-02 NeXstar Pharmaceuticals, Inc. Liposomes coupled to hormones
US5258499A (en) * 1988-05-16 1993-11-02 Vestar, Inc. Liposome targeting using receptor specific ligands
JP2955314B2 (ja) * 1988-10-27 1999-10-04 リージェンツ・オブ・ザ・ユニバーシティー・オブ・ミネソタ Ｉｌ―２含有リポソーム免疫アジュバント
US5234912A (en) * 1989-02-14 1993-08-10 Incyte Pharmaceuticals, Inc. Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
ES2085920T3 (es) * 1989-06-23 1996-06-16 Liposome Co Inc Liposomas dirigidos y metodos de acoplamiento liposoma-proteina.
JPH0363298A (ja) * 1989-07-31 1991-03-19 Green Cross Corp:The コロニー形成刺激因子・脂質複合体
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5268454A (en) 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5817333A (en) * 1991-10-31 1998-10-06 Fujisawa Pharmaceutical Co., Ltd. Liposome preparation containing a tricyclic compound
CA2127107C (en) * 1991-12-31 2007-06-19 Bruce L. A. Carter Methods and compositions for reducing blood loss
US5229109A (en) * 1992-04-14 1993-07-20 Board Of Regents, The University Of Texas System Low toxicity interleukin-2 analogues for use in immunotherapy
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
US5449663A (en) * 1993-06-11 1995-09-12 Bicher; Haim I. Antineoplastic compositions
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6033645A (en) * 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6406689B1 (en) 1995-10-03 2002-06-18 Frank W. Falkenberg Compositions and methods for treatment of tumors and metastatic diseases
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
CA2301575C (en) 1997-05-20 2003-12-23 Ottawa Civic Hospital Loeb Research Institute Vectors and methods for immunization or therapeutic protocols
ATE293994T1 (de) * 1997-12-01 2005-05-15 Fang Fang Multivalente rekombinante antikörper zur behandlung von hrv infektionen
US20010003580A1 (en) * 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
WO1999036056A1 (en) * 1998-01-16 1999-07-22 Biomira Usa Inc. Lipomatrix preparation
US7097849B2 (en) 1998-08-19 2006-08-29 Jagotec Ag Injectable aqueous dispersions of propofol
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
DK1274464T3 (da) 2000-03-13 2012-01-23 Engene Inc Sammensætninger og fremgangsmåder til regulering af proteinekspression i tarm
AU2001249389A1 (en) * 2000-03-22 2001-10-03 The Children's Hospital Of Philadelphia Modified blood clotting factors and methods of use
JP2005522192A (ja) 2001-07-19 2005-07-28 パーラン セラピューティクス， インコーポレイテッド マルチマータンパク質およびマルチマータンパク質を作製および使用する方法
US20030044354A1 (en) * 2001-08-16 2003-03-06 Carpenter Alan P. Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release
TWI461436B (zh) 2005-11-25 2014-11-21 Kyowa Hakko Kirin Co Ltd 人類ｃｄ１３４（ｏｘ４０）之人類單株抗體及其製造及使用方法
EP1795540A1 (en) 2005-11-30 2007-06-13 Imaxio Multimeric complexes of antigens and an adjuvant
EP2015785A4 (en) * 2006-04-24 2009-07-15 Shantha West Inc ANTIGEN AGRM2
US20080199475A1 (en) 2006-11-27 2008-08-21 Patrys Limited Novel glycosylated peptide target in neoplastic cells
ES2571235T3 (es) 2009-04-10 2016-05-24 Kyowa Hakko Kirin Co Ltd Procedimiento para el tratamiento de un tumor sanguíneo que utiliza el anticuerpo anti-TIM-3
CN102459342B (zh) 2009-04-27 2015-01-07 协和发酵麒麟株式会社 用于治疗血液肿瘤的抗il-3ra抗体
US9556272B2 (en) 2009-11-11 2017-01-31 The Trustees Of The University Of Pennsylvania Anti-TEM1 antibodies and uses thereof
US9783610B2 (en) 2012-04-27 2017-10-10 The Trustees Of The University Of Pennsylvania Anti-tumor endothelial marker-1 (TEM1) antibody variants and uses thereof
JP2016514091A (ja) 2013-02-08 2016-05-19 ミスフォールディング ダイアグノスティクス， インコーポレイテッド トランスサイレチン抗体およびその使用
EP3013945B1 (en) 2013-06-25 2020-05-27 Temple University Of The Commonwealth System Of Higher Education Cortical bone-derived stem cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
GB1578776A (en) * 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4377567A (en) * 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
JPS56127308A (en) * 1980-03-11 1981-10-06 Green Cross Corp:The Blood-coagulation factor 8 pharmaceutical
EP0088046B1 (de) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン２を含有してなる癌治療剤
AU564876B2 (en) * 1982-03-29 1987-08-27 Liposome Company, Inc., The Stable plurilamellar vesicles
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
AU573193B2 (en) * 1982-11-23 1988-06-02 Bio-Response Inc. Method for isolating cells
WO1985000606A1 (en) * 1983-07-19 1985-02-14 Takeda Chemical Industries, Ltd. Human il-2 and process for its preparation
US4464461A (en) * 1983-07-22 1984-08-07 Eastman Kodak Company Development of light-sensitive quinone diazide compositions
US4764359A (en) * 1984-05-25 1988-08-16 Lemelson Jerome H Drug compositions and their use in treating human or other mammalian patients
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids

Also Published As

Publication number Publication date
DK155085A (da) 1985-10-10
FR2562421A1 (fr) 1985-10-11
GB2157172A (en) 1985-10-23
CH668554A5 (de) 1989-01-13
AU4094685A (en) 1985-10-17
IL74835A0 (en) 1985-07-31
DK155085D0 (da) 1985-04-03
LU85839A1 (fr) 1985-12-16
IT1199967B (it) 1989-01-05
SE8501709L (sv) 1985-10-10
NL8501010A (nl) 1985-11-01
FR2562421B1 (fr) 1989-02-17
JPS60243022A (ja) 1985-12-03
SE8501709D0 (sv) 1985-04-04
US4863740A (en) 1989-09-05
GB8508809D0 (en) 1985-05-09
JPH0665650B2 (ja) 1994-08-24
GB2157172B (en) 1988-12-29
IT8547939A1 (it) 1986-10-09
DE3512926A1 (de) 1985-10-24

Similar Documents

Publication Publication Date Title
IT8547939A0 (it) Liposomi contenenti interleucina, metodo per la loro preparazione eloro uso terapeutico nelle affezioni tumorali
EP0252286A3 (en) Pharmaceutical preparations for topical use, process for their manufacture and their use
DE3372769D1 (en) 3-aminoquinuclidin derivatives, process for their preparation and their use as therapeutical agents
AU7813191A (en) Novel immunoconjugates and methods for their use in tumor therapy
DE3461466D1 (en) 3',4',5,7-tetrahydroxyflavone derivatives, process for their preparation and their therapeutical use
IT8248431A0 (it) Impiego di dinorfina per uso terapeutico, in particolare per persone trattate con analgesici narcotici
AR243187A1 (es) Procedimiento para preparar derivados del 2-¡4-(pirimidinil-2-amino)-piperidinil-1¿-1h-bencimidazol.
IT8447887A0 (it) Perfezionamento nelle carrozzelle per invalidi
MY8600008A (en) Thieno-pyridine derivatives, their preparation process and their therapeutic use
IT1174797B (it) Calizzatore,nonche' metodo per la preparazione ed utilizzazioni
IL78357A0 (en) Nitrofuran derivatives,the preparation thereof and their application in therapy
GR862249B (en) Dihydropyridin-2-hydroxyamine process for their preparation and their use as medicaments
IT1173473B (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni,in particolare per l'uso nel trattamento di psoriasi
DE3362189D1 (en) 14-amino-steroid derivatives, process for their preparation and their use in therapy
ZA856595B (en) New,1,4-dishydropyridines,processes for their preparation,and their use in medicaments
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
ZM10686A1 (en) New orth-anisamides process for their preparation and their therapeutic application
IT1170862B (it) Mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
IT1187655B (it) Procedimento per la preparazione di w-lattami,in particolare caprolattame
IL70361A0 (en) 3'5'-diarabinosides,their preparation and their application in therapy
KR870004977A (ko) 2,2'-바이-1h-이미다졸 및 그의 제조방법
AR241906A1 (es) Un procedimiento para la preparacion de derivados de n-(2-imidazolinil-alquil)-4-amino-benzamida y sus sales farmacologicamente aceptables
PL252062A1 (en) Method of obtaining pharmaceutical preparations exibiting prolonged therapeutic action
ZA852632B (en) Perhydrothiazepine derivatives,their preparation and their therapeutic use
IT8050469A0 (it) Tiocarnitine procedimento per la loro preparazione e loro uso terapeutico

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970421